Which Discovery Technologies Help Solve Degrader Assay Gaps
Source: Drug Discovery Online
Johannes Yeh says degrader discovery requires robust screening systems to measure target engagement, ternary complex formation, stability, and degradation, supported by tools such as CRISPR, shRNA, and proteomics. Maria Soloveychik adds that her company built a cell-based platform to test induced proximity and degradation intracellularly, using viability as a functional readout before confirming hits with biophysical assays, genomics, mutagenesis, and SAR.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.
Subscribe to Drug Discovery Online
X
Subscribe to Drug Discovery Online